Home Cart Sign in  
Chemical Structure| 522-51-0 Chemical Structure| 522-51-0

Structure of Dequalinium Chloride
CAS No.: 522-51-0

Chemical Structure| 522-51-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dequalinium Chloride is a PKC inhibitor with IC50 of 7-18 μM, and also a selective blocker of apamin-sensitive K+ channels with IC50 of 1.1 μM.

Synonyms: Dequalinium (chloride); NSC 166454; Dequavagyn

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dequalinium Chloride

CAS No. :522-51-0
Formula : C30H40Cl2N4
M.W : 527.57
SMILES Code : CC1=[N+](C2=CC=CC=C2C(N)=C1)CCCCCCCCCC[N+](C3=CC=CC=C3C(N)=C4)=C4C.[Cl-].[Cl-]
Synonyms :
Dequalinium (chloride); NSC 166454; Dequavagyn
MDL No. :MFCD00063502
InChI Key :LTNZEXKYNRNOGT-UHFFFAOYSA-N
Pubchem ID :10649

Safety of Dequalinium Chloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Dequalinium Chloride

epigenetics

Isoform Comparison

Biological Activity

Target
  • PKC

    PKC, IC50:7 μM-18 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK 293 cells 30 μM Inhibited TRPM7-mediated Ca2+ influx PMC3417452
OEC-M1 cells 2 μM 48 hours Evaluating the inhibitory effect of Dequalinium chloride on Cdc7-Dbf4 kinase activity PMC6197782
293T cells 10 μM 24 hours Screening FDA-approved drug library for compounds that interfere with Cdc7-Dbf4 interaction PMC6197782
African green monkey kidney epithelial cell line CV-1 250 μM 3 hours Evaluate the toxicity of Dequalinium to CV-1 cells, showing an IC50 of 250 μM PMC298874
Human breast carcinoma cell line MCF-7 2 μM 3 hours Evaluate the toxicity of Dequalinium to MCF-7 cells, showing an IC50 of 2 μM, 125-fold more toxic than CV-1 cells PMC298874
NB TICs (NB12, NB88R2, NB122R) 100 nM 72 hours Significantly reduced cell viability and induced apoptosis PMC3377336
Yeast cells 0.7-4 μM 24 hours DECA inhibits Su9-Ura3 import into mitochondria PMC4210028
HEK293 cells 0.4 μM Investigated the blocking effect of Dequalinium on hSK1 current, with an IC50 of 0.48 μM. PMC1571896
NB TICs (NB12) 100 nM 24 hours Induced apoptosis, characterized by nuclear morphology changes and increased sub-2n DNA content PMC3377336
CHO-K1 cells 2-10 μM 4 hours DECA inhibits mitochondrial protein translocation and restores AGTP11LG170R trafficking to peroxisomes PMC4210028
Rat cultured sympathetic neurones 0.60 ± 0.05 μM 1-3 minutes To evaluate the inhibitory effect of Dequalinium on SKCa channels in sympathetic neurones, results showed that Dequalinium effectively inhibited the slow afterhyperpolarization (AHP). PMC1909372
Rat superior cervical ganglion (SCG) neurones 0.62 μM Test the inhibitory effect of Dequalinium on SK Ca channels, results showed weak inhibition PMC1571984
Rabbit blood cells 410 μM Test the inhibitory effect of Dequalinium on IK Ca channels, results showed weak inhibition PMC1571984
HEK 293 cells 444 nM To investigate the inhibitory effect of Dequalinium Chloride on hSK1 and rSK2 channels, showing IC50 values of 444 nM and 162 nM for hSK1 and rSK2, respectively. PMC1571906

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Subcutaneous OEC-M1 oral carcinoma xenograft model Oral administration 15 mg/kg Twice a week for six consecutive weeks Evaluating the antitumor activity of Dequalinium chloride in vivo PMC6197782
BDF1 mice I.p. implanted mouse bladder carcinoma MB49 Intraperitoneal injection 2 mg/kg or 4 mg/kg Daily or every other day for 25 days Evaluate the survival prolongation effect of Dequalinium on MB49 tumors, showing a T/C (treated/control ratio) of 190%, more effective than seven anticancer drugs PMC298874
Zebrafish Embryonic development model Solution treatment 20 μM 3 days DECA does not affect zebrafish embryonic development at low concentrations PMC4210028
Rats PGE2-induced hyperalgesia model Subcutaneous injection 50 mg/paw Single administration, measured after 30 minutes To evaluate the effect of Dequalinium on baclofen-induced peripheral antinociception, results showed no significant effect PMC2014648

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02242695 Vulvovaginal Candidiasis Phase 4 Completed - Thailand ... More >> Siriraj Gynaecologic ID and Female STD Unit, Department of Obstetrics & Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Bangkok Noi district, Thailand, 10700 Less <<
NCT01125410 Bacterial Vaginosis Phase 3 Completed - Belgium ... More >> AZ Imelda Ziekenhuis Bonheiden, Belgium AZ St. Dimpna Geel, Belgium AZ Ziekenhuis Oost-Limburg Genk, Belgium AZ Heilig Hart Tienen, Belgium Czech Republic Centrum Ambulantni gynekologie a prodnictvi Brno, Czech Republic Faculty Hospital Brno Brno, Czech Republic University Hospital Hradec Kralove Hradec Kralove, Czech Republic Charles University Prague, Czech Republic Fakultni nemocnice Na Bulovce Prague, Czech Republic Ambulance pro gynekologie a prodnictvi Telc, Czech Republic Germany LMU Munich Munich, Germany Slovakia JLF UK a MFN Martin, Slovakia Switzerland University Hospital of Geneva and Faculty of Medicine Geneva, Switzerland CHUV Lausanne, Switzerland Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.90mL

0.38mL

0.19mL

9.48mL

1.90mL

0.95mL

18.95mL

3.79mL

1.90mL

References

 

Historical Records

Categories